Intellectual Property Magazine
AbbVie antitrust claims over Humira price hikes dismissed
Ben Wodecki
Pharma giant AbbVie has successfully defeated claims that itused patents for its Humira drug to artificially inflate prices,
after a USDistrict Court judge dismissed the case.